Cellectar reports third quarter 2020 financial results and provides a corporate update

Florham park, n.j., nov. 09, 2020 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced financial results for the third quarter ended september 30, 2020 and provided a corporate update.

CLRB Ratings Summary

CLRB Quant Ranking